TABLE 5.
Oxidative and nitrosative stress and endothelial function indicators before and after maximum-intensity exercise.
Indices | T1DM group (mean ± SD) | Control group (mean ± SD) | p T1DM vs. control^ | |||||
|
|
|
||||||
Before | After | P | Before | After | p | Before | After | |
TOS/TOC (μmol L–1) | 321.5 ± 151 | 380.1 ± 153.5 | ≤0.0001* | 164.1 ± 57 | 216.6 ± 74.9 | 0.0000 | ≤0.0001* | ≤0.0001* |
Δ TOS/TOC (%) | 24.2 ± 31.7 | 34.9 ± 31.1 | 0.0311 | |||||
TAS/TAC (μmol L–1) | 361.0 ± 22.2 | 327.0 ± 31.1 | ≤0.0001* | 351.5 ± 26.4 | 360.7 ± 24.5 | 0.04 | NS | ≤0.0001* |
Δ TAS/TAC (%) | 9.4 ± 7.1 | −2.8 ± 5.9 | ≤0.0001* | |||||
OSI | 0.9 ± 0.1 | 1.18 ± 0.5 | ≤0.0001* | 0.47 ± 0.169 | 0.60 ± 0.20 | 0.000 | ≤0.0001* | ≤0.0001* |
Δ OSI | 0.28 ± 0.24 | 0.13 ± 0.09 | 0.0127 | |||||
3NT (nM L–1) | 281.4 ± 205.2 | 347.2 ± 268.4 | ≤0.0001* | 125.3 ± 71.2 | 169.8 ± 91.1 | ≤0.0001* | 0.001 | 0.010 |
Δ 3NT (nM L–1) | 65.8 ± 88.5 | 44.5 ± 50.8 | 0.2569 | |||||
eNOS-3 (ng mL–1) | 15.2 ± 16.6 | 18.1 ± 20.0 | ≤0.0001* | 4.4 ± 2.2 | 5.4 ± 2.2 | ≤0.0001* | ≤0.0001* | ≤0.0001* |
Δ eNOS-3 (ng mL–1) | 2.9 ± 5.3 | 0.9 ± 0.8 | 0.0833 | |||||
VEGF (ng L–1) | 422.4 ± 260.1 | 506.2 ± 344.1 | ≤0.0001* | 308.4 ± 184.2 | 359.8 ± 187.5 | ≤0.0001* | 0.1087 | 0.068 |
Δ VEGF (ng L–1) | 83.8 ± 141.7 | 51.5 ± 34.2 | 0.3775 |
T1DM, type 1 diabetes mellitus; TOS/TOC, total oxidant status; Δ, change; TAS/TAC, total antioxidant status; OSI, oxidative stress index; 3NT, 3-nitrotyrosine; eNOS-3, endothelial nitric oxide synthase 3; VEGF, vascular endothelial growth factor; NS, not significant. *Power of the test for each significant comparison between groups was > 98% (0.98).